Welcome
Admissions
Curriculum
Seminar Program
Research
Faculty
Staff & PostDocs
Students
Alumni & Friends
Medicinal Chemistry HOME
|

|
Leroy B. Townsend, Ph.D.
Albert B. Prescott Professor Emeritus of Medicinal Chemistry, College of Pharmacy
Professor of Chemistry, College of LS&A
University of Michigan
The University of Michigan
College of Pharmacy
428 Church St.
Ann Arbor, Michigan 48109-1065
Phone: (734) 764-7547
Fax: (734) 763-5633
ltownsen@umich.edu
Education
New Mexico, Highlands University, Las Vegas, NM, B.S., Chemistry & Math
New Mexico, Highlands University, Las Vegas, NM, M.S., Chemistry
Arizona State University, Tempe, AZ, Ph.D., Chemistry
Research: Design and Synthesis of Heterocycles and Nucleosides
Our research group is involved in the design, synthesis and development of structurally and mechanistically diverse biological and chemotherapeutic agents. The majority of this research effort is expended in one of the most successful areas for the development of potentially active chemotherapeutic agents, antimetabolites. The antimetabolite approach has been used with considerable success in the search for effective antiviral, antibacterial, antiparasitic, and anti-cancer agents.
The design, synthesis and evaluation of the tricyclic nucleoside 5'-phosphate (TCN-P) is an excellent example of the success which can be achieved by using this approach since TCN-P has been recently placed on Phase II clinical trials as an anti-cancer agent. Human cytomegalovirus (HCMV) is a major cause of sickness and death among AIDS victims, infants and organ transplant patients. Our research group has designed and synthesized a number of compounds in diverse heterocyclic systems (e.g., pyrrolo[2,3-d]pyrimidine, benzimidazole, and purine) as part of a national cooperative drug discovery group supported by NIAID. Several compounds are currently undergoing evaluation for HCMV activity in animal and pre-clinical studies, in addition to a benzimidazole derivative which is currently in Phase II clinical trials against HCMV infections.
Our research group has recently become involved in the design and synthesis of specific compounds as potential anti-AIDS agents. This research is the synthetic component of a rather large NIH Drug Development Program on AIDS research and involves collaborations with biochemists, biochemical pharmacologists, virologists, etc., and complements the anti-cancer and HCMV research.
Teaching
Course Coordinator: Graduate Course, Med Chem 533, Survey of Medicinal Chemistry
A general survey of therapeutic agents in principal use today, with emphasis on their origin, chemistry, and mechanisms of action. For students with a one year course in organic chemistry and Med Chem 532.
Co-Course Coordinator: Graduate Course, Med Chem 550, Ethics and the Responsible Conduct of Research (with Pharmacology 504).
This course is concerned with teaching students about ethics and integrity in science. It takes advantage of case studies that link basic principles with specific examples, and it provides students with opportunities to discuss and develop concepts related to ethics and scientific integrity. This course is aimed at the predoctoral students on the Pharmacological Sciences and Biorelated Chemistry Training Grant.
Undergraduate Course, Med Chem 411, Principles of Medicinal II
This course is a continuation of Medicinal Chemistry 410, and deals with the structures and mechanisms of a variety of drug classess. Topics include hormones, immunosuppresents, steroids, and chemotherapeutics (antiviral, anticancer, antiparasitics, etc.).
Selected Publications
- "Synthesis of the First C3 Ribosylated Imidazo[1,2-a]pyridine C-Nucleoside by Enantioselective Construction of the Ribose Moiety", Kristjan S. Gudmundsson, John C. Drach and Leroy B. Townsend, J. Org. Chem., 63, 984-989 (1998).
- "Design, Synthesis and Antiviral Activity of a-Nucleosides: D-and L- Isomers of Lyxofuranosyl- and (5-Deoxylyxofuranosyl)benzimidazoles", Michael T. Migawa, Jean-Luc Girardet, John A. Walker II, George W. Koszalka, Stanley D. Chamberlain, John C. Drach and Leroy B. Townsend, J. Med. Chem., 41, 1242-1251 (1998).
- "Homo-C-Nucleoside Analogs II. Synthesis and Anomeric Configuration of 4-(2,5-Anhydro-D-Gluco-Pentitol-1-YL)-2-Phenyl-2H-1,2,3-Triazole", Mohammed A.E. Sallam and Leroy B. Townsend, Nucleosides and Nucleotides, 17(7), 1215-1229 (1998).
- "Synthesis of Imidazo[4,5-b]quinoxaline Ribonucleosides as Linear Dimensional Analogs of Antiviral Polyhalogenated Benzimidazole Ribonucleosides", Zhijian Zhu, Sunita Saluja, John C. Drach, and Leroy B. Townsend, J. Chin. Chem. Soc., 45(4), 465-474 (1998).
- "An Improved Synthesis of the Versatile Heterocycle, 4-Amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine", Anthony R. Porcari and Leroy B. Townsend, Synthetic Communications, 28(20), 3835-3843 (1998).
- "Phosphorylation of Triciribine Is Necessary for Activity against HIV Type 1", Roger G. Ptak, Katherine Z. Borysko, Anthony R. Porcari, James L. Buthod, Louis E. Holland, Charles Shipman, Jr., Leroy B. Townsend, and John C. Drach, Aids Research and Human Retroviruses, 14(15), 1315-1322 (1998).
- "Design, Synthesis and Antiviral Activity of a-L-Arabinofuranosyl Derivatives of 2-Substituted-5,6-Dichlorobenzimidazoles," Jean-Luc Girardet, John C. Drach, Stanley D. Chamberlain, George W. Koszalka and Leroy B. Townsend, Nucleosides & Nucleotides, 17(12), 2389-2401 (1998).
Questions/Comments
Rackham School of Graduate Studies | College of Pharmacy
page last modified: Wednesday, 11-Oct-2000 10:24:11 EDT
©2001 University of Michigan
|